Last Updated: September 29, 2026

Details for New Drug Application (NDA): 019928

✉ Email this page to a colleague

NDA 019928 describes CARDIOTEC, which is a drug marketed by Bracco and is included in one NDA. Additional details are available on the CARDIOTEC profile page.

The generic ingredient in CARDIOTEC is technetium tc-99m teboroxime kit. There is one drug master file entry for this compound. Additional details are available on the technetium tc-99m teboroxime kit profile page.

Summary for 019928

Tradename:	CARDIOTEC
Applicant:	Bracco
Ingredient:	technetium tc-99m teboroxime kit
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	N/A
Approval Date:	Dec 19, 1990	TE:		RLD:	No

Expired US Patents for NDA 019928

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bracco	CARDIOTEC	technetium tc-99m teboroxime kit	INJECTABLE;INJECTION	019928-001	Dec 19, 1990	4,705,849	⤷ Start Trial
Bracco	CARDIOTEC	technetium tc-99m teboroxime kit	INJECTABLE;INJECTION	019928-001	Dec 19, 1990	6,056,941	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.